China Regenerative Medicine International Limited

HKG-8158
Hong Kong Stock Exchange
Healthcare Biotechnology
Global Rank
#36080
Country Rank
#787
Market Cap
21.32 M
Price
0.0701
Change (%)
1.79%
Volume
66,000

China Regenerative Medicine International Limited's latest marketcap:

21.32 M

As of 07/23/2025, China Regenerative Medicine International Limited's market capitalization has reached $21.32 M. According to our data, China Regenerative Medicine International Limited is the 36080th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 21.32 M
Revenue (ttm) 11.54 M
Net Income (ttm) 2.26 M
Shares Out 304.25 M
EPS (ttm) 0.01
Forward PE 0.00
Ex-Dividend Date 09/24/2002
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 07/23/2025

China Regenerative Medicine International Limited's yearly market capitalization.

China Regenerative Medicine International Limited has seen its market value drop from HK$3.22 B to HK$167.34 M since 2014, representing a total decrease of 94.80% and an annual compound decline rate (CAGR) of 24.41%.
Date Market Cap(HK$) Market Cap(USD) Change (%) Global Rank
07/23/2025 HK$167.34 M $21.32 M 113.56% 36080
12/31/2024 HK$89.75 M $11.55 M -46.36% 37273
12/29/2023 HK$167.34 M $21.42 M -47.18% 33320
12/30/2022 HK$316.83 M $40.55 M -60.36% 28278
12/31/2021 HK$799.2 M $102.47 M -50.88% 22962
12/31/2020 HK$1.63 B $209.78 M 789.56% 16517
12/31/2019 HK$182.89 M $23.47 M -86.13% 25712
12/31/2018 HK$1.32 B $168.38 M -54.55% 14748
12/29/2017 HK$2.9 B $371.3 M -35.29% 11884
12/30/2016 HK$4.48 B $578.17 M -37.83% 8917

Company Profile

About China Regenerative Medicine International Limited

China Regenerative Medicine International Limited is an investment holding company specializing in healthcare products and services across Hong Kong and mainland China. The company operates through two key segments:

  • Aesthetic Medical and Beauty Services – Offering a range of medical beauty products and treatments.
  • Medical Services – Providing specialized medical products and healthcare solutions.

Originally established as China Bio-Med Regeneration Technology Limited, the company rebranded to its current name in March 2015. Founded in 1995, its headquarters are located in Tsim Sha Tsui, Hong Kong.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.